CareLit · DOI-Nachweis · Zeitschrift für Gastroenterologie
Screening for colorectal cancer: A blinded multicenter phase II diagnostic study for validation of a DNA based stool test (GeneFec2©)
DOI 10.1055/s-0028-1089368
Bibliografische Angaben
Nachweis in CareLit
Autor:innenMM Dollinger, C Gromann, I Kühne, S Behl, J Haerting, WE Fleig
ZeitschriftZeitschrift für Gastroenterologie
Ausgabe09/2008
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Aims: Endoscopy-based screening has been adopted as gold standard for colorectal cancer (CRC) screening in most western countries, although patient acceptance has been disappointing. Screening tests using stool samples would be easy to perform with no risks to the patients, but so far detection rates remain unsatisfactory. Aim: To evaluate validity and feasibility of a DNA based stool screening test (GeneFec2©) in c…
Zitieren
Zitierempfehlung
MM Dollinger, C Gromann, I Kühne, S Behl, J Haerting, WE Fleig (2008) Screening for colorectal cancer: A blinded multicenter phase II diagnostic study for validation of a DNA based stool test (GeneFec2©). Zeitschrift für Gastroenterologie (09). https://doi.org/10.1055/s-0028-1089368
Mit CareLit weiterarbeiten